0000899243-19-016953.txt : 20190613
0000899243-19-016953.hdr.sgml : 20190613
20190613212542
ACCESSION NUMBER: 0000899243-19-016953
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190612
FILED AS OF DATE: 20190613
DATE AS OF CHANGE: 20190613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Satvat Ali J.
CENTRAL INDEX KEY: 0001621788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38533
FILM NUMBER: 19897467
MAIL ADDRESS:
STREET 1: C/O KOHLBERG KRAVIS ROBERTS & CO.
STREET 2: 2800 SAND HILL ROAD, SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eidos Therapeutics, Inc.
CENTRAL INDEX KEY: 0001731831
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463733671
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-391-9740
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2550
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-12
0
0001731831
Eidos Therapeutics, Inc.
EIDX
0001621788
Satvat Ali J.
C/O EIDOS THERAPEUTICS, INC.
101 MONTGOMERY STREET, SUITE 2550
SAN FRANCISCO
CA
94104
1
0
1
0
Stock Option (right to buy)
30.87
2019-06-12
4
A
0
21528
0.00
A
2029-06-11
Common Stock
21528
21528
D
The shares subject to this option shall vest and become exercisable in a single installment on the earlier of (i) the first anniversary of the grant date, so that all of the underlying shares shall be vested on June 12, 2020, or (ii) the Issuer's next annual meeting of stockholders, in each case subject to the Reporting Person's continued service with the Issuer through the vesting date. This option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a Sale Event (as defined in the Issuer's 2018 Stock Option and Incentive Plan, as amended).
/s/ Franco Valle, as Attorney-in-Fact
2019-06-13